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Background: Chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers contribute to a
considerable amount of mortality in the U.S. annually. The inability of these wounds to heal has now been associated
with the presence of microbial biofilms. The aim of this study was to determine if products secreted by S. aureus
biofilms play an active role in chronic wounds by promoting inflammation, which is a hallmark of chronic wounds.
Methods: In vitro experiments were conducted to examine changes in gene expression profiles and inflammatory
response of human epithelial keratinocytes (HEKa) exposed to products secreted by S. aureus grown in biofilms or
products secreted by S. aureus grown planktonically.
Results: After only two hours of exposure, gene expression microarray data showed marked differences in
inflammatory, apoptotic, and nitric oxide responses between HEKa cells exposed to S. aureus biofilm conditioned
media (BCM) and HEKa cells exposed to S. aureus planktonic conditioned media (PCM). As early as 4 hours post
exposure, ELISA results showed significant increases in IL-6, IL-8, TNFα, and CXCL2 production by HEKa cells exposed
to BCM compared to HEKa cells exposed to PCM or controls. Nitric oxide assay data also showed significant increases
in nitric oxide production by HEKa cells treated with BCM compared to HEKa cells treated with PCM, or controls.
Conclusions: Taken together, these results support and extend previous findings that indicate products secreted by
S. aureus biofilms directly contribute to the chronic inflammation associated with chronic wounds.
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Each year millions of people are stricken with chronic
wounds such as diabetic foot ulcers, pressure ulcers, and
venous leg ulcers that contribute to the morbidity and
mortality in the U.S. annually [1-3]. Recent evidence in-
dicates that bacterial biofilms are present in chronic
wounds more often than in acute wounds and are re-
lated to the wounds inability to heal [4-6]. Bacterial
biofilms consist of bacterial communities embedded in a
self-made extracellular polysaccharide matrix that are often
resistant to a variety of antibiotics [7]. Chronic wounds
provide an excellent environment for this matrix due to
the tissue surface for growth, poor blood flow, and poor* Correspondence: rbrennan1@uco.edu
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distribution, and reproduction in any mediumoxygen flow that inhibit host cell defenses against the bac-
teria [8]. The surface of chronic wounds allow bacteria to
readily adhere to a surface and relinquish their planktonic
state to form an aggregate of bacteria that enable the newly
formed biofilms to better survive in their environment [9].
The inhibitions of the host cell defenses allow the bacteria
to cooperate in the distribution of nutrients, removal of
wastes, and to resist host defense mechanisms [6].
The establishment of S. aureus biofilms in chronic
wounds relies on the bacterial community’s ability to ad-
here to tissue. After attachment, the bacteria rapidly se-
crete cell signaling molecules that coordinate activities
of the bacteria through a process known as quorum
sensing [10]. Biofilm formation by Staphylococcus aureus
has been shown to be highly dependent on the staphylo-
coccal accessory regulator (sarA) [11] and to a certain
degree on the (icaABCD) operon [12-15], and the walRKtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
Tankersley et al. Journal of Inflammation 2014, 11:17 Page 2 of 11
http://www.journal-inflammation.com/content/11/1/17operon [16]. Mutations in either sarA or the ica operon
have been associated with reduced capacity of S. aureus
to form biofilms. There is significant evidence that the
molecules in the matrix of biofilms lead to impermeabil-
ity to antibiotics and host defenses [17]. While the idea
that biofilms affect wound healing has been established,
the exact role of biofilms in chronic wounds is not well
understood [7]. Biofilm’s resistance to antibiotics make
the infections difficult to resolve and more likely to be-
come chronic or recurrent infections in part due to the
inhibition of the re-epithelialization process [18].
Wound healing is a complex series of pathogen and
host cell interactions. Most chronic skin wound healing
is mediated by keratinocytes [19,20]. The ability of kera-
tinocytes to migrate to the site of the wound and re-
spond to inflammatory signals to eliminate infection and
complete the process of reepithelialization is key to the
ability of chronic wounds to heal [20]. Keratinocytes have
been shown to express toll-like receptors 1–6 and 9, which
can allow them to act as a first responder against patho-
genic microorganisms. For example, S. aureus can activate
nuclear transcription factor kB (NF-κB) in keratinocytes.
Activated NF-κB then translocates into the nucleus and in-
duces the transcription of NF-κB controlled genes such
as interleukin 8 (IL-8) and nitric oxide synthase (iNOS)
[21,22]. The role that keratinocytes play in wound patho-
genesis makes them an excellent model to investigate the
pathogenesis of wound healing in vitro.
Inflammatory response of the host is important to the
ability of wounds to heal. Biofilms have been shown to
contribute to the failure of wounds to reepithelialize
through the activation of the β-catenin/c-myc pathways
which is in part attributed to the unresponsiveness of cells
at the wounds edge [23-25]. A part of that inflammatory
response is the production of inflammatory cytokines that
serve to mediate host immune responses. Recent evidence
has revealed that S. aureus biofilms affect the gene regula-
tion and cytokine production of keratinocytes and thus
may affect the way that wounds heal [26]. The goal of this
project was to further investigate and compare the effects
of S. aureus biofilm secreted products and S. aureus plank-
tonic secreted products on gene expression profiles and in-
flammatory responses of human epithelial keratinocytes
(HEKa). The hypothesis is that products secreted by S. aur-
eus growing as a biofilm actively impair wound healing by
promoting inflammatory responses in keratinocytes. To
test this hypothesis, we investigated and compared inflam-
matory responses of HEKa cells exposed to BCM and
PCM at both transcriptional and translational levels.
Methods
Preparation of biofilm conditioned media
An overnight culture of Staphylococcus aureus ATCC
6538 in 5.0 ml of tryptic soy broth (TSB) was incubatedstatically at 37°C for 24 hours. Tissue culture inserts
were placed in a 24 well plate and inoculated with 10 μl
of overnight culture and 500 μl of TSB and inoculated at
37°C for 72 hours. Every 24 hours during that 72 hour
period the TSB supernatant was removed, the inserts
were moved to new wells in the 24 well plates, and
500 μl of fresh TSB was added to the wells. At the end of
72 hour period the TSB was removed and 500 μl of phos-
phate buffered saline pH 7.4 (PBS) was added and left for 1
hour to wash the remaining TSB from the tissue culture
insert. After the removal of the PBS, 500 μl of Epilife media
(Invitrogen, Carlsbad, CA) was added and incubated for
24 hours at 37°C. The new biofilm conditioned media was
then removed from the well and filtered with a 0.45 μm
syringe and collected in 15 ml centrifuge tubes. This BCM
collecting and filtering procedure was repeated every
24 hours for 3 days. The collected BCM was then pooled
and frozen at −20°C until it was needed.
Preparation of planktonic conditioned media
An overnight culture was created by inoculating a col-
ony of S. aureus ATCC 6538 into 5.0 μl of TSB for 24
hours at 37°C on a rotary shaker set at 150 rpm. After
incubation the S. aureus culture was centrifuged for 7
minutes at 1500 rpm. The supernatant was then re-
placed with PBS, and the pellet was re-suspended by
thoroughly mixing with a pipette. The S. aureus was
then centrifuged for 7 minutes at 1500 rpm and the PBS
was decanted. Five milliliters of Epilife media with hu-
man keratinocyte growth supplement was then added to
the washed S. aureus culture and mixed thoroughly with
a pipette. The S. aureus in the Epilife media was then in-
cubated for 24 hours at 37°C on a rotary shaker set at
150 rpm. After 24 hours the culture was centrifuged at
1500 rpm for 7 minutes and the supernatant was dec-
anted and filtered with a 0.45 μm syringe and stored at
-20°C until needed.
Culturing of human keratinocytes
HEKa cells (Invitrogen, Carlsbad, CA) were seeded into
a T-25 and T-75 tissue culture flasks at 1 x 104 cells/ml
along with Epilife media with human keratinocyte growth
supplement and 100μg/ml and 100 U/ml of pen/strep and
incubated at 37°C in a CO2 incubator. Every 48 hours the
Epilife media was changed until the cells reached 80-90%
confluence. In our hands, HEKa cells would start to be-
come senescent at about passage 8 or 9. To prevent cell
senescent from altering the results all experiments were
performed with cells at passages 3 or 4.
XTT HEKa cell viability assay
BCM and PCM that was created previously were warmed
to room temperature and diluted to1 mg/ml in Epilife
media with human keratinocyte growth supplement. HEKa
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ence and then the original Epilife media with human
keratinocyte growth supplement media was removed
and 300 μl of either the PCM, BCM or media was
added to the wells in triplicate and incubated for 0, 2, 4,
8, 24, and 48 hours. At the designated time 60 μl of ac-
tivated 2, 3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide (XTT) solution was added and
absorbance read at 450 nm.
Genomic responses, statistics and bioinformatics analyses
HEKa cell genomic responses to PCM, BCM and Epilife
media were also evaluated. HEKa cells were cultured and
plated in a 24 well plate as described above and were
grown to 80-90% confluence. After reaching 80-90% con-
fluence the cells were exposed to 1.0 ml of PCM, BCM or
Epilife media for a period of 0 and 2 hours. At the desig-
nated times points the BCM, PCM, and Epilife media was
removed, and the cells liberated from the wells for RNA
extraction using Qiagen RNAeasy Cell Protect kit (Qiagen
Inc. Valencia, CA). The concentrations of the RNA were
determined using a Nanodrop spectrophotometer. RNA
was diluted to a 0.1 μg/ml concentration in RNase-free
water and transported to Oklahoma Medical Research
Foundation (OMRF) for microarray analysis. RNA quality
was assessed using capillary gel electrophoresis (2100
Bioanalyzer, Agilent Technologies, Santa Clara, CA). Sam-
ples were labeled using Illumina TotalPrep RNA Amplifi-
cation kit (Ambion/Life Technologies, Carlsbad, CA) and
hybridized to whole genome gene expression microarrays
(Illumina Human HT-12 v4 BeadChips, Illumina Inc., San
Diego, CA) according to manufacturers’ instructions.
Microarrays were stained and washed under high strin-
gency conditions and were then scanned on an Illumina
iSCAN scanner. Signal intensity values were obtained using
GenomeStudio software (Illumina, v2011.1) and quantile
normalized and log transformed using MatLab software
(Mathworks, Inc., Natick MA) prior to importing into
BRB-Array Tools ( National Cancer Institute, Biometric
Research Branch, Rockville, MD). Genes were then filtered
using the Log Expression Variance Filter to screen out
genes that are not likely to be informative based on the
variance of each gene across the arrays. Biological repli-
cates for each group were designated and statistically sig-
nificant differentially expressed genes were identified using
a 5% false-discovery rate and a minimum 1.5 fold change
between the BCM and the PCM samples [27]. Bioinfor-
matics analyses of differentially expressed genes were
performed using Ingenuity Pathways Analysis software
(Ingenuity Systems, Redwood City, CA).
Detection of inflammatory cytokines
HEKa cells were cultured to 80-90% confluence in 24 well
plates 1.0 ml of BCM, PCM or Epilife media withoutpen/strep was added in triplicate cultures for periods of 0,
2, 4, and hours. At the designated time points the BCM,
PCM and Epilife media was collected and stored in 1.5 ml
microcentrifuge tubes at -20°C until ELISA tests were
performed. The concentrations of cytokines in the PCM,
BCM, and Epilife media products that were exposed to
HEKa cells were quantified and analyzed. Quantification of
TNF-α IL-1, IL-6, and IL-8 was performed using the corre-
sponding Quantikine Colorimetric sandwich ELISA assay
kit (R&D Systems, Minneapolis, MN) following the manu-
facturer’s instructions. CXCL2 was quantified using Abnova
Enzyme-Linked Immunoabsorbant Sandwich Elisa Assay
Kit (Abnova Industries, Taipei City, Taiwan).
Ntiric oxide detection
Cell culture supernatants were collected, and the accu-
mulation of nitrite (NO2
−), a stable end product of NO
formation, was measured as an indicator of NO produc-
tion. The concentration of nitrite in the samples was cal-
culated from a standard curve of sodium nitrite [28].
Briefly, at four and eight hours post exposure one hun-
dred microliters of supernatants were collected from
HEKa cells exposed to PCM, BCM, or control media
samples and added in triplicate to the 96 well plates.
One hundred microliters of Griess reagent was then
added to all wells and incubated at room temperature
for 15 minutes, and then absorbance was measured at
570 nm. After incubation the optical densities of each
well were read on a Thermo Scientific Multiskan MCC
microplate reader (Fisher Scientific, Pittsburgh PA) at
570 nm.
Statistical analysis
To determine if there were significant differences in the
cell viability of HEKa cells exposed to PCM, BCM and
the control media two-tailed t-tests were completed. To
determine if there were significant differences in the
mean concentration of the cytokines or nitric oxide be-
tween the three types of materials, two-tailed t-tests were
completed along with ANOVA and Tukey’s statistical
methods. An ANOVA resulting in a significant p-value
(p < 0.05) was followed by Tukey’s Honestly Significant




HEKa cell viability experiments were conducted to de-
termine at which point in time if any products secreted
by S. aureus growing as a biofilm or S. aureus growing
planktonically significantly reduced viability of HEKa cells.
The XTT viability assay was used to determine the loss of
HEKa viability after exposure to PCM, BCM, or Epilife
media. After 8 hours exposure there was a significant
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posed cells (Figure 1). Based on these results it was estab-
lished that sampling time points of 2 hours for microarray
analysis and 4 and 8 hours for inflammation analysis
would be used.
Transcriptional responses of HEKa cells exposed to BCM
or PCM
We predicted that HEKa cells exposed to S. aureus bio-
film secreted products would display differential genes
expression when compared to HEKa cells exposed to
S. aureus planktonically secreted products or the media
controls. To test this hypothesis we extracted HEKa
cellular RNA after 2 hours of exposure to BCM, PCM,
or media controls and subjected the RNA to Illumina
microarray analysis in order to evaluate differential gene
expression. The data was filtered so that only genes that
had a 1.5 fold changes or greater over the media control
were shown (Table 1). Analysis revealed that HEKa cells
exposed to BCM or to PCM had genes associated with
inflammation, apoptosis, and nitric oxide production up-
regulated when compared to the media controls. When
cells exposed to BCM were compared to those cells ex-
posed to PCM, the cells exposed to BCM had an in-
crease in the number and fold increases of transcriptional
products. The microarray analysis identified 43 genes that
were uniquely expressed in BCM exposed HEKa cells with
a 1.5 or greater fold change in expression that were not
expressed in HEKa cells exposed to PCM or the media
control (Table 1). Of these genes 42 had an upregulation of

















Figure 1 HEKa cell viability. HEKa cells were treated with Media, PCM or
added and the absorbance read at 540nm. Results represent the mean and
viabilities are stated as percent viable of untreated controls at each time po
treatment and the control (p < 0.05).19 are associated with inflammatory response in eukaryotic
cells. Eleven genes associated with inflammation were also
differentially expressed in HEKa cells exposed to PCM, 9
of which were also differentially expressed in cells exposed
to BCM (Table 2) and (Figure 2A). The largest increase in
gene expression in HEKa cells exposed to BCM for genes
associated with inflammatory response versus HEKa cells
exposed to BCM were DUSP1, CXCL2, IL-8, ATF3, IL-6
and NFKBIA (Table 1 ).
Nitric oxide (NO) is an important molecule for in-
flammation and the reepithelialization of skin. Low
concentrations of NO have been found to inhibit ad-
hesion molecule suppression cytokines and chemokine
synthesis and leukocyte adhesion and migration [29,30].
This promotes collagen production either directly or
through mediators and thus affects collagen synthesis
or breakdown in the wound [31]. While low amounts
of NO can be beneficial to wound repair large amounts
of NO generation has been shown to be toxic, pro-
inflammatory, and cause the wound to enter a cycle
where healing does not occur [32,33]. Because of this,
microarray results were filtered to look for genes that
are associated with the production of nitric oxide (NO).
The results showed that at two hours after treatment
there were several differentially expressed genes associ-
ated with NO production that were uniquely upregu-
lated in HEKa cells exposed to BCM (Table 1). This
upregulation was not seen in HEKa cells treated with PCM
for two hours. Of these genes DUSP1, JUN, IL-6, and
ADM were up regulated the most. Most of the genes above









BCM for up to 8 hours. At 0, 2, 4, and 8 hours post exposure XTT was
standard deviation of three independent experiments. Percent
int. (*) indicates a statistically significant difference between the
Table 1 Change in gene expression profiles for genes that
were uniquely expressed in BCM exposed HEKa cells after
2 hr of exposure




CXCL2 (inflammation) 15.082 -
IL8 (inflammation) 9.530 -
DUSP1 (inflammation/NO prod.) 9.061 -
IL6 (inflammation/NO prod.) 4.623 -
NFKBIA (inflammation) 4.093 -
EFNA1 (inflammation) 3.990 -
TNFAIP3 (inflammation) 3.964 -
ADM (inflammation/NO prod.) 2.917 -
CXCL1 (inflammation) 2.850 -
IL1B (inflammation/NO prod.) 2.586 -
ZFP36 (inflammation) 2.540 -
IFI27 (inflammation) 2.411 -
TNF (inflammation/NO prod.) 2.333 -
IL1A (inflammation/NO prod.) 2.113 -
PTGS2 (inflammation/NO prod.) 2.084 -
SMAD7 (inflammation) 2.073 -
IL20 (inflammation) 1.655 -
IL24 (inflammation) 1.540 -
MMP1 (inflammation) −1.650 -
FOS (apoptosis) 8.433 -
ZC3H12A (apoptosis) 4.361 -
NR4A2 (apoptosis) 4.121 -
SGK1 (apoptosis) 3.045 -
CYP1B1 (apoptosis) 2.709 -
CYR61 (apoptosis) 2.587 -
BMP2 (apoptosis) 2.481 -
SLC25A24 (apoptosis) 2.467 -
CEBPD (apoptosis) 2.419 -
IFI27 (apoptosis) 2.411 -
BIRC3 (apoptosis) 1.643 -
HES1 (growth & proliferation) 4.280 -
DUSP10_v3 (growth & proliferation) 4.091 -
EFNA1 (growth & proliferation) 3.990 -
PPP1R15A (growth & proliferation) 3.582 -
JUN (growth & proliferation/NO prod.) 3.523 -
PPP1R10 (growth & proliferation) 3.099 -
HBEGF (growth & proliferation) 3.053 -
CYR61 (growth & proliferation) 2.587 -
CEBPD (growth & proliferation) 2.419 -
JUNB (growth & proliferation) 2.405 -
SMAD7 (growth & proliferation) 2.073 -
DUSP10_v1 (growth & proliferation) 1.764 -
CYR61 (wound healing) 2.587 -
Genes identified through Illumina microarray results filtered to represent a 1.5
or greater fold change over the expression in the control sample.
Table 2 Change in gene expression profiles for genes
associated with Inflammation































Genes identified through Illumina microarray results filtered to represent a 1.5
or greater fold change over the expression in the control sample.
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in human keratinocytes [34]. Oxidative stress has been
found to increase the amount of IFN-γ produced by the
cells which in turn regulates the transcription of DUSP1
and ADM which ultimately leads to increases in apoptosis.
IFN-γ along with TNF-α stimulates the production of nitric
oxide in keratinocytes as a response to oxidative stress
[35]. IFN-γ has been found to increase the production of
NO in keratinocytes as much as 20-30%. IFN-γ has also
been linked to an increase in production of IL-6 along with
NO production [36]. In addition to upregulation of genes
associated with NO production, we observed down-
regulation of ARG1, which is known to be associated
with NO production in both BCM and PCM, exposed
HEKa cells relative to control media (Table 3) and
Figure 2 Venn diagrams representing the number of genes that were altered in HEKa cells exposed to BCM (on the right), PCM
(on the left), or shared genes (in the middle). The Venn diagram (A) represents genes associated with inflammation, (B) represents genes
associated with NO production, and (C) represents genes associated with apoptosis.
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keratinocytes overproducing NO in patients with psoria-
sis and basal carcinomas. The inhibition of ARG1 may
then allow NO to inhibit cell proliferation and the failure
of wounds to reepithelialize [37].
Inflammatory cytokine responses in HEKa cells exposed
to BCM or PCM
In an effort to corroborate the microarray results, we
assessed the production of the protein levels of several
of the most markedly upregulated genes associated with
an inflammatory response. ELISAs were used to measure
the production of IL-1, IL-6, IL-8, TNF-α, and CXCL2.
Cytokine measurements were performed at 4 and 8 hourspost exposure to BCM or PCM. ELISA data showed that
as soon as 4 hours post exposure, there were significantly
greater (p < 0.05) levels of IL-6, TNF-α, and CXCL2 in
HEKa cells exposed to BCM compared to HEKa cells ex-
posed to PCM or control media (Figure 3A). The levels
of IL-6 and CXCL2 were even greater at 8 hours post ex-
posure and the significant differences between the groups
were maintained (Figure 3B). In addition to these three
cytokines, the levels of IL-8 were also significantly greater
(p < 0.05) after 8 hours of exposure in HEKa cells ex-
posed to BCM compared to HEKa cells exposed to PCM,
or controls (Figure 3B). PCM exposed HEKa cells did not
produce significantly greater cytokine levels compared to
the media controls at either time point.
Table 3 Gene expression profiles for genes associated
with NO production










Genes identified through Illumina microarray results filtered to represent a 1.5
or greater fold change over the expression in the control sample.
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The microarray data revealed an increase in the expres-
sion of genes associated with the production of nitrite in
BCM-exposed HEKa cells. In an effort to corroborate
these results, we performed nitric oxide assays on the
HEKa cell culture supernatants to quantify the amount
of nitrate produced by the HEKa cells exposed to PCM,
BCM and control media. The nitrite assay data showed
that HEKa cells exposed to BCM produced significantly
greater (p < 0.05) amounts of nitrite at both 4 and 8
hours post exposure than HEKa cells exposed to PCM
or the media controls (Figure 4). There were no detect-
able levels of nitrite from the media controls.
Discussion
The data collected in this study reveal a clearer picture
of the role that S. aureus biofilms play on cultured kera-
tinocytes. Keratinocytes serve as the primary cell type in
the epidermis and primarily function in providing a bar-
rier between the external and internal environment.
When breaks in this barrier occur, basal keratinocytes
migrate to the site and reepithelization ensues. Chronic
wounds are characterized by prolonged inflammation
and the failure of wound reepithelization [8]. Chronic
wounds activate a number of inflammatory pathways
that lead to the prevention of keratinocyte migration,
growth, and differentiation and thus failure of wounds to
heal [25]. Due to their importance in chronic wound
pathogenesis HEKa cells were chosen for experiments
on the effect of biofilms on early chronic wound patho-
genesis. Kirker et al. [8] demonstrated that the viability
of HEKa cells was significantly reduced when exposed to
BCM or PCM for 24 hours. Results from our HEKa cell
viability assays showed that viability was significantly re-
duced by BCM or PCM in as little as 8 hours of expos-
ure (Figure 1), indicating that our findings are in general
agreement with previous findings of Kirker et al.[8]. Visual
inspection of the cells showed morphological differencesbetween HEKa cells exposed to the two treatment condi-
tions. Evidence of cellular stress in the form of rounding of
cell membranes and decreased culture confluency were ob-
served in HEKa cells exposed to BCM after 8 hours of ex-
posure that was not seen in HEKa cells exposed to PCM
or the control media (data not shown). Based on the viabil-
ity assay results and these morphological changes, tran-
scriptional changes were measured at two hours after
treatment to detect early transcriptional changes in cell
populations with high viabilities. For inflammatory cyto-
kine response and NO production 4 and 8 hour time inter-
vals were used. These time points were selected in an
effort to measure downstream effects of transcription and
inflammatory responses.
Increased apoptotic effects in HEKa cells exposed to
S. aureus biofilm secreted products provides greater un-
derstanding of the pathogenesis of wound healing. De-
creased cell viability and the inability of wounds to heal
have been linked to chronic wounds associated with bio-
films [8]. Figure 2C shows alterations in transcription of
genes associated with apoptosis in BCM- and PCM-
exposed HEKa cells. This correlates with our cell viabil-
ity data (Figure 1) which reveals a statistically significant
loss of HEKa cell viability in BCM and PCM after 8
hours. There are several definitions of what an actual
chronic wound is, but some common themes are a pro-
longed inflammatory phase to the wounds and the fail-
ure of the wound to respond to standard treatments
[38]. These wounds fail to reepithelialize which is due in
part to the decrease of cell production and the increase
in cell death. Our data indicate that there is an increase
in apoptotic effect in HEKa cells exposed to BCM over
PCM or the control conditions.
Microarray analysis was performed on RNA gathered
after 2 hours exposed to BCM, PCM, or the media con-
trol the samples of HEKa cells exposed for 0 hours were
used as a control. The data were then filtered in order to
identify differentially expressed genes that were associ-
ated with inflammatory responses, apoptosis and nitric
oxide production in HEKa cells. There was an increase
in transcriptional activity in HEKa cells exposed to BCM
for genes associated with inflammation, apoptosis and
NO production (Figure 2). In HEKa cells exposed to
BCM some of the largest upregulation of transcriptional
activity came from the genes CXCL2, IL-8, DUSP1, and
ATF3. The DUSP1 gene is important for the regulation
of p38 activation of LPS-activated macrophages. The
p38 pathway plays a central role in multiple pathways as-
sociated with inflammatory response in many cell types
[39,40]. The p38 MAPK pathway has been found to play a
role in the production of inflammatory cytokines namely
IL-1 and TNF-α but has also been found to contribute to
the production of IL-8 in response to IL-1 osmotic shock
















Figure 3 ELISA results for PCM, BCM and control treated HEKa cells. HEKa cells were treated with Media, PCM or BCM for up to 8 hours. The
levels of cytokine production were measured after 4 and 8 hours of exposure. (A) Cytokine measurements after 4 hours of exposure. (B) Cytokine
measurement after 8 hours of exposure. Measurements are reported in pg/ml concentrations. Analysis of variance (ANOVA) and Tukey’s Honestly
Significant Difference were performed to identify statistically significant differences. Results represent the mean and standard deviation of three
independent experiments. (#) indicates a significant difference between PCM and BCM and (*) indicates a statistically significant difference
between BCM and media (p < 0.05).
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lator that induces innate and adaptive immune responses.
NFKBIA is one of the genes that assist in the regulation of
the magnitude and duration of inflammatory responses.
One of its key roles is to prevent the inflammatory re-
sponse from destroying excessive amounts of tissue [41].
Some of the other genes up regulated are associated with
the production of inflammatory cytokines or chemokines.
CXCL2, IL-6 and IL-8 are well known cytokines or chemo-
kines which play important roles in mediating inflam-
matory responses to pathogen. CXCL2 and IL-8 are
pro-inflammatory chemokines that assist in the medi-
ation of neutrophil migration as well as the migration ofother cellular and humeral factor components to the site
of an infection. TNF-α, IL-6 and IL-8 were also upregu-
lated but the fold change in expression over the control
was much lower and the increase in expression was only
seen in HEKa cells exposed to BCM. TNF-α, IL-6 and IL-1
are all multifunctional cytokines with a wide variety of
functions. These three cytokines are interrelated with IL-1
and TNF-α inducing IL-6 and IL-6 in turn playing a role in
the regulation of TNF-α [42]. TNF-α plays a role in tissue
repair, inflammation and regulation of apoptosis as well as
the activation of transcriptional factors such as NFΚB that
are important to several processes including growth, death,























Figure 4 Nitrite assay. HEKa cell culture supernatants were collected
and treated with Griess Reagent and absorbance was measured at
570nm. Measurements were taken at 4 and 8 hours. Measurements are
reported in μM. ANOVA and Tukey’s Honestly Significant Difference
were performed to identify statistically significant differences. Results
represent the mean and standard deviation of three independent
experiments. (#) indicates a statistically significant difference between
the PCM and BCM and (*) indicates a statistically significant difference
between media and BCM (p < 0.05).
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be differentially expressed, Ingenuity Pathways Analysis
software predicted its increased activation based on the ex-
pression patterns of 28 genes in the microarray results
from BCM-treated but not PCM-treated HEKa cells rela-
tive to media controls (p = 1.06 x 10−11). DUSP1 is pro-
duced in human skin cells and specifies a protein with
structural features similar to members of non-receptor-
type protein-tyrosine phosphatase family which inactivates
MAPKs. MAPKs play an important role in the human cel-
lular response to environmental stress as well in the nega-
tive regulation of cellular proliferation [44]. This can lead
to an increase in cell death and thus contribute to S. aureus
biofilms’ negative effects on the ability of HEKa cells ability
to respond to bacterial challenges and prevent apoptosis
and promote reepithelialization.
Seven cytokines or chemokines commonly produced
by keratinocytes in response to pathogens were tested
using sandwich ELISAs [45-47]. After 4 hours, cells ex-
posed to BCM showed statistically significant increases
in concentrations of IL-6, TNF-α, and CXCL2 in HEKa
cells exposed to BCM over HEKa cells exposed to PCM
and the control media. The increase in inflammatory
cytokine and chemokine responses after 4 hours of ex-
posure to PCM, BCM, and the media control were in
general agreement with earlier research by Secor et al.
[6] who showed increases in inflammatory responses
by HaCaT cells exposed to S. aureus biofilm products.
HEKa cells exposed to PCM, BCM and the control
media were also tested by ELISA’s for the same seven cy-
tokines and chemokines. After 8 hours of exposure,levels of IL-8, along with previously elevated IL-6, TNF- α,
and CXCL2 significantly increased in HEKa cells exposed
to BCM over HEKa cells exposed to PCM and the media
control. At the 8 hour time point HEKa cells treated with
BCM showed a statistically significant increase in cytokines
versus HEKa cells treated with PCM. These findings sup-
port the current hypothesis that biofilm-secreted products
differ and have more dramatic effects than secreted prod-
ucts from planktonically grown bacteria which may con-
tribute to difference between chronic and acute wounds
[5]. The creation of biofilms enables bacteria to increase
their interaction with one another and thus resist antibac-
terial and environmental pressures [6]. These biofilms are
not only a congregate of bacterial cells but are also held to-
gether by a polysaccharide matrix. Understanding the com-
ponents of the exopolysaccharide matrix produced by
bacterial biofilms along with the difference in morphology
of the cells may provide clues to the mechanisms of bio-
films and why they produce the differential inflammatory
responses that we have observed.
A somewhat unexpected finding from the microarray
analysis was the upregulation of genes associated with
nitric oxide production in HEKa cells exposed to BCM.
Nine genes were up regulated in HEKa that were not
found in control samples. Eight of those genes were
unique to HEKa cells exposed to BCM and were not
found in HEKa cells exposed to planktonically secreted
products. Despite the genes associated with nitric oxide
production there was not a significant upregulation of
iNOS or NOS2 which are most often associated with ni-
trite production in cells. The lack of significant iNOS an
NOS2 upregulation may have been due to the short time
between the exposure of the HEKa cells to the PCM and
BCM and the time of mRNA collections. Schnorr et al.
reported that iNOS expression in keratinocytes was not
detected until 4–8 hours after exposure to inflammatory
cytokines and maximal expression does not occur until
24 hours post exposure [48]. Nitric oxide plays a key
role in acute wound repair. Nitric oxide synthesis in-
creases wound healing by enhancing collagen deposition
within the wound and in dermal fibroblasts to enhance
the mechanical strength of the tissue [29,30]. However,
high concentrations NO may actually inhibit healing
[31]. In this study, we observed upregulation of genes as-
sociated with NO production in cells treated with BCM,
and tested the downstream effects of such genes by per-
forming nitrite assays on culture supernatants. These ni-
trite assays were done in order to measure nitrite as an
index of NO formation. Statistically significant increases
in the amount of nitrite produced by HEKa cells exposed
to BCM compared to HEKa cells exposed to PCM or just
Epilife media were detected. These results add to the un-
derstanding of NO role in chronic wounds as opposed to
acute wounds. The role of NO in biofilm production and
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terms of Neisseria gonorrhea biofilms there was a high level
of NO which seemed to aid the biofilm’s growth. Other
studies have found that NO has been linked to the disper-
sal of Pseudomonas aeruginosa biofilms as well the preven-
tion of biofilm formation in S.aureus and Escherichia coli
[50,51]. It has been suggested that the disparate results are
due to concentration of NO that is induced in the system.
NO in large concentrations can be toxic to eukaryotic cells
and in fact eukaryotic cells have developed defenses like
metallothionein in response to oxidative stress [32]. Our
results show that NO production by HEKa cells increased
over time (Figure 4) as inflammatory effects of biofilm se-
creted products increased (Figure 3). Overproduction of
reactive nitrogen species can impair cellular migration,
proliferation, and synthesis of extracellular matrix that is
important to wound healing by keratinocytes [35]. This
lack of agreement between studies coupled with our results
makes NO and its role in biofilm formation, dispersal, and/
or chronic wound pathogenesis a topic that requires fur-
ther investigation.
The majority of studies on immune responses to bac-
teria have been carried out with planktonically growing
bacteria or cell components from planktonically grow-
ing bacteria. Infections due to S. aureus are character-
ized by strong inflammatory responses [52,53]. Several
molecules such as Panton-Valentine leukocidin [54]
sphingomyelinase [55], peptidoglycan, lipoteichoic acid
[56,57], superantigens [58] as well as others have been
shown to play a role in the inflammatory response di-
rected towards S. aureus. It is possible that some of
these same molecules may be responsible for the differ-
ences in inflammatory and nitric oxide responses we have
measured; however, these molecules have not been specif-
ically linked to S. aureus biofilms and chronic wound
inflammation.
Conclusion
Studies presented here further our understanding of the
role that S. aureus biofilms may play in chronic wound
pathogenesis. We found greater transcriptional activity
in HEKa cells exposed to BCM compared to HEKa cells
exposed to PCM or the media controls. The increased
transcriptional activity was corroborated by increases in
inflammatory cytokine production, nitric oxide produc-
tion, and reduced cell viability. The increase in nitrite
production in HEKa cells exposed to BCM is an intri-
guing finding that could be an important biofilm-
mediated factor that contributes to the failure of chronic
wounds to heal and warrants further investigation. Experi-
ments to further understand the role of nitric oxide in
chronic wounds and studies to identify S. aureus biofilm
secreted factors responsible for the increased inflammatory
responses are planned.Competing interests
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